
|Articles|September 2, 2020
Serialisation Regulations in the EU and USA
Author(s)PDA
This chapter, excerpted from the book Good Distribution Practice, provides background on serialization and how, despite initial investment of time and money, it will allow greater tracking of medicinal product through the drug supply chain and reduce the chance that falsified medicines end up in the hands of the public.
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Everything to Know about BMS & NVidia’s AI Supercomputer
3
Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs
4
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
5